"Designing Growth Strategies is in our DNA"

Dermatology Drugs Market Size, Share & COVID-19 Impact Analysis, By Application (Acne, Psoriasis, Atopic Dermatitis, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI104432

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Dermatologic Conditions, By Key Countries, 2025
    2. New Product Launches, By Key Players
    3. Pipeline Analysis
    4. Key Industry Developments: Mergers, Acquisitions and Partnerships
    5. Impact of COVID-19 on the Market
  5. Global Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Application
      2. Canada
        1. By Application
  7. Europe Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
        1. By Application
      2. Germany
        1. By Application
      3. France
        1. By Application
      4. Italy
        1. By Application
      5. Spain
        1. By Application
      6. Scandinavia
        1. By Application
      7. Rest of Europe
        1. By Application
  8. Asia Pacific Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
        1. By Application
      2. Japan
        1. By Application
      3. India
        1. By Application
      4. Australia
        1. By Application
      5. Southeast Asia
        1. By Application
      6. Rest of Asia Pacific
        1. By Application
  9. Latin America Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Application
      2. Mexico
        1. By Application
      3. Rest of Latin America
        1. By Application
  10. Middle East & Africa Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
        1. By Application
      2. South Africa
        1. By Application
      3. Rest of Middle East & Africa
        1. By Application
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Profiles of Players Operating in the Market
      1. AbbVie, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      2. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      3. Pfizer, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      5. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      6. GALDERMA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      7. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      8. Almirall, S.A
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      9. Bausch Health Companies Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Dermatologic Conditions, By Key Countries, 2025
    2. New Product Launches, By Key Players
    3. Pipeline Analysis
    4. Key Industry Developments: Mergers, Acquisitions and Partnerships
    5. Impact of COVID-19 on the Market
  5. Global Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Application
      2. Canada
        1. By Application
  7. Europe Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
        1. By Application
      2. Germany
        1. By Application
      3. France
        1. By Application
      4. Italy
        1. By Application
      5. Spain
        1. By Application
      6. Scandinavia
        1. By Application
      7. Rest of Europe
        1. By Application
  8. Asia Pacific Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
        1. By Application
      2. Japan
        1. By Application
      3. India
        1. By Application
      4. Australia
        1. By Application
      5. Southeast Asia
        1. By Application
      6. Rest of Asia Pacific
        1. By Application
  9. Latin America Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Application
      2. Mexico
        1. By Application
      3. Rest of Latin America
        1. By Application
  10. Middle East & Africa Dermatology Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Application
      1. Acne
      2. Atopic Dermatitis
      3. Psoriasis
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
        1. By Application
      2. South Africa
        1. By Application
      3. Rest of Middle East & Africa
        1. By Application
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Profiles of Players Operating in the Market
      1. AbbVie, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      2. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      3. Pfizer, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      5. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      6. GALDERMA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      7. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      8. Almirall, S.A
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
      9. Bausch Health Companies Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (based on availability)
Read Less

Figure 01: Global Dermatology Drugs Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 02: Global Dermatology Drugs Market Value Share (%), By Application, 2025 & 2034

Figure 03: Global Dermatology Drugs Market Value Share (%), By Route of Administration, 2025 & 2034

Figure 04: Global Dermatology Drugs Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 05: Global Dermatology Drugs Market Value Share (%), By Region, 2025 & 2034

Figure 06: North America Dermatology Drugs Market Value (USD billion), by Application, 2025 & 2034

Figure 07: North America Dermatology Drugs Market Value Share (%), by Application, 2025

Figure 08: North America Dermatology Drugs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 09: North America Dermatology Drugs Market Value Share (%), by Route of Administration, 2025

Figure 10: North America Dermatology Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 11: North America Dermatology Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 12: North America Dermatology Drugs Market Value (USD billion), by Country, 2025 & 2034

Figure 13: North America Dermatology Drugs Market Value Share (%), by Country, 2025

Figure 14: Europe Dermatology Drugs Market Value (USD billion), by Application, 2025 & 2034

Figure 15: Europe Dermatology Drugs Market Value Share (%), by Application, 2025

Figure 16: Europe Dermatology Drugs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 17: Europe Dermatology Drugs Market Value Share (%), by Route of Administration, 2025

Figure 18: Europe Dermatology Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 19: Europe Dermatology Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 20: Europe Dermatology Drugs Market Value (USD billion),

Figure 21: Europe Dermatology Drugs Market Value Share (%),

Figure 22: Asia Pacific Dermatology Drugs Market Value (USD billion), by Application, 2025 & 2034

Figure 23: Asia Pacific Dermatology Drugs Market Value Share (%), by Application, 2025

Figure 24: Asia Pacific Dermatology Drugs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 25: Asia Pacific Dermatology Drugs Market Value Share (%), by Route of Administration, 2025

Figure 26: Asia Pacific Dermatology Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 27: Asia Pacific Dermatology Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 28: Asia Pacific Dermatology Drugs Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 29: Asia Pacific Dermatology Drugs Market Value Share (%),

Figure 30: Latin America Dermatology Drugs Market Value (USD billion), by Application, 2025 & 2034

Figure 31: Latin America Dermatology Drugs Market Value Share (%), by Application, 2025

Figure 32: Latin America Dermatology Drugs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 33: Latin America Dermatology Drugs Market Value Share (%), by Route of Administration, 2025

Figure 34: Latin America Dermatology Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 35: Latin America Dermatology Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 36: Latin America Dermatology Drugs Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 37: Latin America Dermatology Drugs Market Value Share (%), by Country/Sub-region, 2025

Figure 38: Middle East and Africa Dermatology Drugs Market Value (USD billion), by Application, 2025 & 2034

Figure 39: Middle East and Africa Dermatology Drugs Market Value Share (%), by Application, 2025

Figure 40: Middle East and Africa Dermatology Drugs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 41: Middle East and Africa Dermatology Drugs Market Value Share (%), by Route of Administration, 2025

Figure 42: Middle East and Africa Dermatology Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 43: Middle East and Africa Dermatology Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 44: Middle East and Africa Dermatology Drugs Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 45: Middle East and Africa Dermatology Drugs Market Value Share (%), by Country/Sub-region, 2025

Figure 46: Global Dermatology Drugs Market Share (%), By Company, 2025

Table 01: Global Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 02: Global Dermatology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021–2034

Table 03: Global Dermatology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 04: Global Dermatology Drugs Market Revenue (USD billion) Forecast, By Region, 2021–2034

Table 05: North America Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 06: North America Dermatology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021–2034

Table 07: North America Dermatology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 08: North America Dermatology Drugs Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 09: U.S. Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 10: Canada Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 11: Europe Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 12: Europe Dermatology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021–2034

Table 13: Europe Dermatology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 14: Europe Dermatology Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 15: U.K. Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 16: Germany Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 17: France Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 18: Italy Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 19: Spain Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 20: Scandinavia Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 21: Rest of Europe Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 22: Asia Pacific Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 23: Asia Pacific Dermatology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021–2034

Table 24: Asia Pacific Dermatology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 25: Asia Pacific Dermatology Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 26: China Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 27: Japan Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 28: India Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 29: Australia Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 30: Southeast Asia Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 31: Rest of Asia Pacific Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 32: Latin America Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 33: Latin America Dermatology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021–2034

Table 34: Latin America Dermatology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 35: Latin America Dermatology Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 36: Brazil Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 37: Mexico Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 38: Rest of Latin America Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 39: Middle East and Africa Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 40: Middle East and Africa Dermatology Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021–2034

Table 41: Middle East and Africa Dermatology Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 42: Middle East and Africa Dermatology Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 43: GCC Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 44: South Africa Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

Table 45: Rest of Middle East and Africa Dermatology Drugs Market Revenue (USD billion) Forecast, By Application, 2021–2034

  • 2021-2034
  • 2025
  • 2021-2024
  • 169
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann